| Divis Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.15 | 5.39 | 5.42 | 4.74 | 3.74 |
| Fixed Assets | 1.26 | 1.17 | 1.27 | 1.72 | 1.66 |
| Inventory | 3.06 | 2.66 | 2.81 | 3.79 | 3.59 |
| Debtors | 3.59 | 3.62 | 3.36 | 4.12 | 4.15 |
| Interest Cover Ratio | 1465.50 | 534.00 | 1178.00 | 2126.16 | 1452.86 |
| PBIDTM (%) | 36.23 | 32.77 | 35.38 | 44.92 | 42.43 |
| PBITM (%) | 31.87 | 27.87 | 30.90 | 41.42 | 38.68 |
| PBDTM (%) | 36.20 | 32.72 | 35.36 | 44.90 | 42.40 |
| CPM (%) | 28.38 | 25.47 | 28.20 | 36.70 | 32.50 |
| APATM (%) | 24.02 | 20.56 | 23.71 | 33.20 | 28.75 |
| ROCE (%) | 20.63 | 16.27 | 19.27 | 35.01 | 31.55 |
| RONW (%) | 15.57 | 12.04 | 14.82 | 28.13 | 23.57 |